Shelf life (days): 1460.0
Formulation: A solid
Formal Name: (3R,5S,E)-7-(4-(4-fluorophenyl)-2-(N-methylmethylsulfonamido)-6-(propan-2-yl-1,1,1,3,3,3-d6)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate, monosodium salt
Purity: ≥98%
Formula Markup: C22H21D6FN3O6S / Na
Formula Weight: 509.556933
CAS Number: 2070009-41-3
Notes: Rosuvastatin-d6 is intended for use as an internal standard for the quantification of rosuvastatin (Item Nos. 12029 / 18813) by GC- or LC-MS. Rosuvastatin is an inhibitor of HMG-CoA reductase (IC50 = 5 nM).{15309} It inhibits cholesterol synthesis in isolated rat hepatocytes with an IC50 value of 0.16 nM.{58863} Rosuvastatin (10 mg/kg) reduces plasma total cholesterol, triglyceride, LDL-C, and oxidized LDL-C levels in Ldlr-/- mice fed a high-fat diet.{58864} It decreases the area of aortic atherosclerotic lesions in the same model. Formulations containing rosuvastatin have been used in the treatment of dyslipidemias.